IceCure Medical Ltd (ICCM)
$1.78
+0.03 (+2.01%)
Rating:
Recommendation:
-
| Symbol | ICCM |
|---|---|
| Price | $1.78 |
| Beta | 1.785 |
| Volume Avg. | 0.03M |
| Market Cap | 65.532M |
| Shares () | - |
| 52 Week Range | 1.684-12.4 |
| 1y Target Est | - |
| DCF Unlevered | ICCM DCF -> | |
|---|---|---|
| DCF Levered | ICCM LDCF -> | |
| ROE | - | |
| ROA | - | |
| Operating Margin | - | |
| Debt / Equity | 25.03% | Neutral |
| P/E | - | |
| P/B | - |
Latest ICCM news
About
Download (Excel)IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.